Rptc Rinecker Proton Therapy Center
Rptc Rinecker Proton Therapy Center is a privately-held, operating proton therapy facility. The source provides no company-specific operational detail beyond its name, private status, and active operating state; the broader category delivers particle-accelerator-based targeted radiotherapy for cancer patients.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Rptc Rinecker Proton Therapy Center does
Rptc Rinecker Proton Therapy Center is identified in the source data as a privately-held entity with current operating status and no disclosed parent company. No founding date, management team, headcount, or ownership structure is available in the supplied data, and the source explicitly notes the inability to confirm company type, operating status details, or revenue from the available material.
The associated article provides general background on proton therapy technology rather than company-specific operational detail. Proton therapy is described as an advanced form of radiotherapy in which hydrogen nuclei (protons) are accelerated in particle accelerators—up to approximately 180,000 kilometers per second—and delivered to tumors via the Bragg-peak principle, which concentrates maximum energy at the tumor while sparing surrounding healthy tissue. The article cites a clinical claim that up to 50% of cancer patients could experience significantly fewer side effects versus conventional photon radiotherapy, and references several thousand patients treated at Universitätsklinikum Dresden (a separate institution, not RPTC).
Because the supplied input does not include RPTC-specific facts such as treatment indications offered, installed accelerator capacity, patient throughput, payor mix, geographic catchment, leadership, or financials, the company description is necessarily limited to what can be grounded: RPTC is a privately-held operating entity in the proton therapy space, and the broader technological context for its category of service.
Rptc Rinecker Proton Therapy Center firmographics
Firmographics- Name
- Rptc Rinecker Proton Therapy Center
- Website
- https://rptc.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rptc Rinecker Proton Therapy Center is a privately-held, operating proton therapy facility. The source provides no company-specific operational detail beyond its name, private status, and active operating state; the broader category delivers particle-accelerator-based targeted radiotherapy for cancer patients.
- Ownership category
- akta.pro rank
Rptc Rinecker Proton Therapy Center industry classification
Industry- Product category
- Cancer Treatment Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Rptc Rinecker Proton Therapy Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Technology or R&D, Operations
Rptc Rinecker Proton Therapy Center product offering
Product offeringCore offering
Rptc Rinecker Proton Therapy Center is a specialized medical facility that provides proton beam radiation therapy for cancer patients. The center uses particle accelerators to deliver targeted proton radiation to tumors, leveraging the Bragg-Peak principle to concentrate maximum energy within the tumor while sparing surrounding healthy tissue, and is particularly focused on treating tumors in complex anatomical regions and pediatric cases.
Differentiator
Problem solved
Functional benefit
Products and services
- Proton Therapy for Cancer Treatment
Companies that use Rptc Rinecker Proton Therapy Center
Customer profileIdeal customer profiles2 records
Rptc Rinecker Proton Therapy Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Rptc Rinecker Proton Therapy Center competitors and assessment
Company assessmentBroad incumbents
- IBA (Ion Beam Applications): Broad incumbent: Belgian-based leader in proton therapy system manufacturing and operator of several proton therapy sites globally; adjacent supplier and operator relative to RPTC's clinical business model.
- Varian Medical Systems (Siemens Healthineers): Broad incumbent: leading manufacturer of proton therapy systems (e.g., ProBeam) and broader radiation oncology equipment; supplier-side adjacency to proton therapy operators like RPTC and competitor for capital budgets across the industry.
Regional players
- CNAO – Centro Nazionale di Adroterapia Oncologica: Regional peer: Italian hadron therapy center providing proton and carbon-ion treatment for comparable oncology indications, primarily serving the Italian and broader European patient pool rather than the German market.
- The Christie NHS Foundation Trust – Proton Beam Therapy Centre: Regional peer: major UK NHS proton beam therapy center operating the same high-precision modality for similar cancer indications, primarily serving UK patients rather than the German market where RPTC operates.
- Institut Curie – Centre de Protonthérapie d'Orsay: Regional peer: French proton therapy center at Institut Curie/Orsay, offering comparable precision radiotherapy services in a different European geography from RPTC.
- MedAustron: Regional peer: Austrian ion beam therapy center offering proton and carbon-ion therapy; serves a similar clinical indication set but is geographically distinct from RPTC's German footprint.
Direct peers
- Charité – BerlinProtonen: Direct peer: proton therapy program at Berlin's Charité university hospital, another German site offering the same precision radiotherapy modality for similar indications as RPTC.
- Heidelberg Ion Beam Therapy Center (HIT): Direct peer: leading German particle therapy center at Heidelberg University Hospital offering proton and carbon-ion therapy, overlapping directly with RPTC on indications, referring physician base, and capital-intensive operating model.
- Westdeutsches Protonentherapiezentrum Essen (WPE): Direct peer: German proton therapy center operated by University Hospital Essen; competes for pediatric and adult proton therapy patients in the German market alongside RPTC.
- Universitätsklinikum Carl Gustav Carus Dresden – Protonentherapiezentrum: Direct peer: German university hospital-based proton therapy center that the article cites as having treated 'several thousand patients' using proton therapy; competes for the same German patient pool and indications as RPTC.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks3 records
Key highlights3 records
Customer concentration
Rptc Rinecker Proton Therapy Center social profiles
Digital presenceRptc Rinecker Proton Therapy Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rptc Rinecker Proton Therapy Center leadership team
Management profileNumber of profiles
Rptc Rinecker Proton Therapy Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rptc Rinecker Proton Therapy Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rptc Rinecker Proton Therapy Center
What does Rptc Rinecker Proton Therapy Center do?
Rptc Rinecker Proton Therapy Center is a specialized medical facility that provides proton beam radiation therapy for cancer patients. The center uses particle accelerators to deliver targeted proton radiation to tumors, leveraging the Bragg-Peak principle to concentrate maximum energy within the tumor while sparing surrounding healthy tissue, and is particularly focused on treating tumors in complex anatomical regions and pediatric cases.
Is Rptc Rinecker Proton Therapy Center a public or private company?
Rptc Rinecker Proton Therapy Center is a private company. It is classified as unknown and is currently operating.
When was Rptc Rinecker Proton Therapy Center founded?
Rptc Rinecker Proton Therapy Center was founded in -1. It employs 11 to 50 people.
Who are Rptc Rinecker Proton Therapy Center's main competitors?
Broad incumbents on record are IBA (Ion Beam Applications) and Varian Medical Systems (Siemens Healthineers). Regional players are CNAO – Centro Nazionale di Adroterapia Oncologica, The Christie NHS Foundation Trust – Proton Beam Therapy Centre, Institut Curie – Centre de Protonthérapie d'Orsay and MedAustron. Direct peers are Charité – BerlinProtonen, Heidelberg Ion Beam Therapy Center (HIT), Westdeutsches Protonentherapiezentrum Essen (WPE) and Universitätsklinikum Carl Gustav Carus Dresden – Protonentherapiezentrum.
Does Rptc Rinecker Proton Therapy Center have an API?
No public API is recorded for Rptc Rinecker Proton Therapy Center.
What industry is Rptc Rinecker Proton Therapy Center in?
Rptc Rinecker Proton Therapy Center's product category is Cancer Treatment Services. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8000.